Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
International Bancshares
IBOC
$4.72B
| $1.36M | ﹤0.01% |
29,704
+18,965
| +177% | +$913K |
|
|
TGVC
2502
DELISTED
TG Venture Acquisition Corp. Class A Common Stock
TGVC
| $1.36M | ﹤0.01% |
133,904
| – | – |
|
2503
Navient
NAVI
$880M
| $1.36M | ﹤0.01% |
82,501
-14,604
| -15% | -$231K |
|
2504
Trustmark
TRMK
$2.83B
| $1.35M | ﹤0.01% |
38,736
-56,898
| -59% | -$1.99M |
|
2505
PUT
Beyond Meat
BYND
$314M
| $1.35M | ﹤0.01% |
+109,600
| New | +$1.53M |
|
2506
WSFS Financial
WSFS
$4.23B
| $1.35M | ﹤0.01% |
29,705
+10,292
| +53% | +$484K |
|
|
GRP.U
2507
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $1.35M | ﹤0.01% |
+26,409
| New | +$1.41M |
|
|
SPR
2508
DELISTED
Spirit AeroSystems
SPR
| $1.35M | ﹤0.01% |
45,461
-7,279
| -14% | -$189K |
|
2509
Design Therapeutics
DSGN
$849M
| $1.34M | ﹤0.01% |
130,999
+109,401
| +507% | +$1.48M |
|
2510
Vanguard Dividend Appreciation ETF
VIG
$114B
| $1.34M | ﹤0.01% |
8,838
+8,730
| +8,083% | +$1.3M |
|
2511
The RMR Group
RMR
$324M
| $1.34M | ﹤0.01% |
47,440
+10,333
| +28% | +$281K |
|
2512
Axalta
AXTA
$8.15B
| $1.34M | ﹤0.01% |
52,537
-11,147
| -18% | -$275K |
|
2513
Benchmark Electronics
BHE
$3.02B
| $1.33M | ﹤0.01% |
49,999
+7,689
| +18% | +$213K |
|
|
NARI
2514
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $1.33M | ﹤0.01% |
20,976
-12,838
| -38% | -$931K |
|
2515
Lincoln Electric
LECO
$15.2B
| $1.33M | ﹤0.01% |
9,216
-374
| -4% | -$52.5K |
|
2516
Kennametal
KMT
$2.6B
| $1.33M | ﹤0.01% |
55,343
-16,315
| -23% | -$404K |
|
2517
Ares Capital
ARCC
$13.9B
| $1.33M | ﹤0.01% |
72,006
-457,947
| -86% | -$8.6M |
|
2518
AAR Corp
AIR
$5.91B
| $1.33M | ﹤0.01% |
29,552
+3,169
| +12% | +$138K |
|
|
VIGL
2519
DELISTED
Vigil Neuroscience
VIGL
| $1.32M | ﹤0.01% |
105,893
+3,730
| +4% | +$45.8K |
|
|
AXNX
2520
DELISTED
Axonics, Inc. Common Stock
AXNX
| $1.32M | ﹤0.01% |
21,123
-4,556
| -18% | -$302K |
|
|
KZR
2521
DELISTED
Kezar Life Sciences
KZR
| $1.32M | ﹤0.01% |
18,749
+3,428
| +22% | +$254K |
|
2522
HSBC
HSBC
$352B
| $1.32M | ﹤0.01% |
42,352
-20,062
| -32% | -$569K |
|
|
EGLE
2523
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $1.32M | ﹤0.01% |
26,414
+10,187
| +63% | +$511K |
|
2524
Midland States Bancorp
MSBI
$711M
| $1.31M | ﹤0.01% |
49,276
+6,257
| +15% | +$166K |
|
|
WIRE
2525
DELISTED
Encore Wire Corp
WIRE
| $1.31M | ﹤0.01% |
9,523
+1,472
| +18% | +$204K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.